Radiopharm Theranostics Limited (ASX:RAD)

Radiopharm Theranostics Revenue

In the fiscal year ending June 30, 2026, Radiopharm Theranostics had annual revenue of 12.87M AUD, down -1.05%. Radiopharm Theranostics had revenue of 6.66M in the half year ending June 30, 2026. That makes Radiopharm Theranostics the 37,931st largest company in the world by revenue and 690th in Australia.

• Revenue: 12.87M
• Revenue Growth: -1.05%
• P/S Ratio: 1.35
• Revenue / Employee: 918.94K
• Employees: 14
• Market Cap: 17.35M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	12.87M	-136.84K	-1.05%
Jun 30, 2025	13.00M	11.41M	716.81%
Jun 30, 2024	1.59M	-4.62M	-74.37%
Jun 30, 2023	6.21M	-	-
Jun 30, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 6, 2026

Data Sources Report a data error